ストックスクリーナーアプリを入手
0.2385
12.38%
0.0285
Cosmos Health Inc (COSM) 最新ニュース
Cosmos Health Introduces Four 18 Series Products with Projected Annualized Revenue and Gross Profit in the United States - marketscreener.com
Cosmos Health projects $22.7M revenue from U.S. product line - Investing.com
Cosmos Health Provides Update on United States Portfolio; - GlobeNewswire
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit - marketscreener.com
Science-driven 18 Series aims for $17M profit in U.S. launch - Stock Titan
Why Tower Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Cosmos Health (COSM) Secures New Contract Manufacturing Orders - GuruFocus
Cosmos Health Gets New Contract Manufacturing Orders for 253,657 Units Across Multiple Medicines - marketscreener.com
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines - GlobeNewswire
Cosmos Health Stock (COSM) Opinions on EU Expansion and Antiseptic Sales Growth - Quiver Quantitative
Cosmos Health (NASDAQ: COSM) CEO swaps $45K company debt for shares - Stock Titan
Cosmos Health sets three-year targets for antiseptic brands By Investing.com - Investing.com Australia
Cosmos Health sets three-year targets for antiseptic brands - Investing.com
C-Scrub antiseptic tops $1.5M, aims for $7.4M across Europe - Stock Titan
Cosmos Health (NASDAQ: COSM) CEO gets 701K shares for $160K debt - Stock Titan
Cosmos Health Signs Letter of Intent to Buy Doc Pharma - Moomoo
Cosmos Health (COSM) Plans Acquisition of Doc Pharma - GuruFocus
Cosmos Health director awarded 20,000 shares | COSM Insider Trading - Stock Titan
Cosmos Health (NASDAQ: COSM) director receives 20,000-share equity award via RSU conversion - Stock Titan
Cosmos Health (NASDAQ: COSM) awards Demetriades 20K shares, now holding 55K - Stock Titan
Director at Cosmos Health (NASDAQ: COSM) awarded 40,000 shares - Stock Titan
Cosmos Health (COSM) grants 20,000 shares of stock to director - Stock Titan
Cosmos Health (NASDAQ: COSM) CFO receives 850K-share equity award via RSU conversion - Stock Titan
Cosmos Health (COSM) CEO awarded 2.35M shares via RSU conversion - Stock Titan
Cosmos Health Inc. Announces Proposed Acquisition of Doc Pharma S.A. to Enhance Vertical Integration and Product Portfolio - Quiver Quantitative
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio - The Manila Times
Cosmos Health pursues Doc Pharma deal, adding $6.7M in sales - Stock Titan
Cosmos Health Secures Additional 180-Day Nasdaq Extension To Regain Bid Price Compliance - TradingView
Cosmos Health gets Nasdaq extension to regain $1 minimum bid price - Investing.com
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance - The Manila Times
Cosmos Health gets Dec. 7 deadline from Nasdaq; reverse split only last resort - Stock Titan
Cosmos Health (COSM) Secures Manufacturing Deal with Verisfield S.A. - GuruFocus
Cosmos Health CEO addresses shareholders amid stock decline - Investing.com UK
Cosmos Health targets $200M revenue by 2029, driven by U.S. expansion - scanx.trade
$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM) - Barchart.com
$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM) | FinancialContent - FinancialContent
Cosmos Health subsidiary secures manufacturing deal By Investing.com - Investing.com Australia
Cosmos Health subsidiary secures manufacturing deal - Investing.com
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries - The Manila Times
Cosmos Health Inc. - Via Ritzau
Cosmos Health CEO addresses shareholders amid stock decline By Investing.com - Investing.com Nigeria
Cosmos Health CEO Issues Letter to Shareholders: Building - GlobeNewswire
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare PlatformRecord Growth with U.S. Expansion Underway - The Manila Times
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com UK
Cosmos Health (COSM) Launches New Capsule Production and Signs C - GuruFocus
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com Canada
Cosmos Health Inc. Subsidiary Cana Laboratories Inaugurates New Capsule Production Line and Secures Contract with Provident Pharmaceuticals - Quiver Quantitative
Cosmos Health Inaugurates State-of-the-Art Capsule - GlobeNewswire
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line With New 5-Year Contract Manufacturing Agreement With Provident Pharmaceuticals for 385,000 Units of CERTORUN - 富途牛牛
Cosmos Health (COSM) Expands Innovation with Patent Acquisition - GuruFocus
Cosmos Health subsidiary acquires nanotechnology patent By Investing.com - Investing.com Australia
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives - The Globe and Mail
Cosmos Health subsidiary acquires nanotechnology patent - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Acquires International Patent to Enhance Nanotechnology Investment Initiatives - Quiver Quantitative
Cosmos Health Completes Acquisition of Strategic - GlobeNewswire
Press Release: Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives - Moomoo
Cosmos Health acquires patent, expands nanotechnology initiatives - scanx.trade
8.91%
0.20%
大文字化:
|
ボリューム (24 時間):